Pottsgrove OKs Contracts For Special Education Services

Pottsgrove’s district office

POTTSTOWN PA – For some special education students that the Pottsgrove School District cannot adequately serve, and for other students already at its buildings who may temporarily need help with personal problems, the Board of School Directors has again turned to the experience of professionals.

During the past two months (May and June 2012), directors approved contracts with outside providers that total more than $101,000 to meet district obligations for special education and counseling. They include:

  • The Vanguard School of Malvern PA, for services during the 2012-2013 academic year, $45,640;
  • The Academy, for services next year at the rate of $123 per student per day;
  • Creative Health Services Inc. of Pottstown, to serve next year as liaison for the elementary Student Assistance Program, $18,800;
  • The Pathway School of Norristown PA, for extended school year services for one student through Aug. 17, $8,550;
  • Valley Forge Educational Services of Malvern PA, for extended school year services for three students through Aug. 3, $21,225; and
  • Wordsworth Academy of Fort Washington and Philadelphia PA, for extended school year services for one student through Aug. 17, $7,500.
Share

4 Responses to “Pottsgrove OKs Contracts For Special Education Services”

Trackbacks/Pingbacks

  1. [...] Pottsgrove OKs Contracts For Special Education Services Some cover the current vacation period. Others are for the 2012-2013 academic year. They total more than $101,000. [...]

  2. [...] Pottsgrove OKs Contracts For Special Education Services Some cover the current vacation period. Others are for the 2012-2013 academic year. They total more than $101,000. [...]

  3. [...] Pottsgrove OKs Contracts For Special Education Services Some cover the current vacation period. Others are for the 2012-2013 academic year. They total more than $101,000. [...]

  4. [...] Pottsgrove OKs Contracts For Special Education Services Some cover the current vacation period. Others are for the 2012-2013 academic year. They total more than $101,000. [...]


From Our Sponsors

RSS Health News

  • FDA probes deaths of two patients on Lilly schizophrenia drug June 18, 2013
    (Reuters) - The Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co's long-acting treatment for schizophrenia, Zyprexa Relprevv. […]
  • AstraZeneca turnaround is 3-4 year journey, says CEO June 18, 2013
    LONDON (Reuters) - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief executive said on Tuesday. […]
  • GSK negotiating $1 billion sale of thrombosis drugs to Aspen June 18, 2013
    LONDON (Reuters) - GlaxoSmithKline is discussing the sale of its thrombosis drug brands Arixtra and Fraxiparine, along with a related French factory, to Aspen Pharmacare in a deal that could be worth some $1 billion. […]
  • WHO urges tougher food marketing rules to curb childhood obesity June 18, 2013
    LONDON (Reuters) - The marketing of unhealthy foods to children has proven "disastrously effective", driving obesity by using cheap social media channels to promote fat-, salt- and sugar-laden foods, the World Health Organisation's Europe office said on Tuesday. […]
  • AstraZeneca picks site for new global home in Cambridge June 18, 2013
    LONDON (Reuters) - AstraZeneca has chosen a science park on the southern outskirts of Cambridge, England, next to the world-renowned Addenbrooke's Hospital, for its new $500 million global headquarters and research center. […]
  • J&J in $1 billion deal to bolster prostate-cancer focus June 17, 2013
    (Reuters) - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired another experimental prostate-cancer treatment four years ago that has become a leading brand. […]
  • Medtronic bone graft has limited benefit, may cause harm: reviews June 17, 2013
    (Reuters) - Two long-awaited independent reviews of a controversial Medtronic Inc bone growth product show it works as well as traditional bone grafts taken from patients, but it may not be as safe. […]
  • Wait-and-see may be best for early prostate cancer June 17, 2013
    NEW YORK (Reuters Health) - Watching and routinely examining men with early, slow-growing prostate cancer is more effective and cheaper than sending them to surgery or radiation right away, according to a new study. […]
  • Saudi Arabia says MERS coronavirus kills four more June 17, 2013
    DUBAI (Reuters) - Four more people have died and three more have fallen ill in Saudi Arabia from the new SARS-like coronavirus MERS-CoV, the Saudi Health Ministry said on Monday. […]
  • Blood tests could detect sexually-transmitted oral cancers June 17, 2013
    LONDON (Reuters) - Antibodies to a high-risk type of a virus that causes mouth and throat cancers when transmitted via oral sex can be detected in blood tests many years before onset of the disease, according to a World Health Organisation-led team of researchers. […]

The Posts On Health At Twitter